N.Y. Racing Regulators Amend Medication Rules
Tom Precious
December 12, 2012
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
A panel discussed dealing with drug violators in horse racing and reported progress.
The winner of the Darley Prix Jean Romanet was disqualified after testing positive for an anti-inflammatory.
The six medications were identified by the AAEP as having therapeutic purposes.
A World Horse Welfare representative spoke on the topic at the 2012 FEI General Assembly, held Thursday.
Samples were screened for more than 45 anabolic steroids and hundreds of other prohibited drugs.
Furosemide has been banned from this year’s Breeders’ Cup juvenile races.
All Pletcher’s 2-year-olds have raced on Salix in all of their starts.
The trainers were recently involved in medication violations in Louisiana and New Mexico.
Furosemide, clenbuterol, and owner education were among the topics discussed during the Welfare Summit.
Officials imposed the first round of rules intended to make it safer for racehorses on Oct. 11.
Officials will implement new rules recommended by a task force report to improve equine safety.
Chairman Louis Romanet applauded The Jockey Club’s efforts to prohibit race-day medication in U.S. racing.
A Kentucky state veterinarian accidentally administered furosemide to a racehorse at Keeneland on Oct. 5.
The fourth edition of the Welfare and Safety of the Racehorse Summit will be held Oct. 16-17.
The changes being implemented Jan. 1 include the addition of five new substances and other amendments.
Stay on top of the most recent Horse Health news with
